Cargando…
Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
Mesenchymal stem cells (MSCs) ameliorate the renal injury in Adriamycin (ADR)-induced nephropathy, but the mechanisms underlying their efficacy remain incompletely understood. In this study, we demonstrated that MSCs increased the survival, recovered body weight loss, and decreased proteinuria and s...
Autores principales: | Kim, Hyung Sook, Lee, Jae Seob, Lee, Hong Kyung, Park, Eun Jae, Jeon, Hye Won, Kang, Yu Jeong, Lee, Tae Yong, Kim, Kyung Suk, Bae, Sang-Cheol, Park, Ji Hyun, Han, Sang-Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829076/ https://www.ncbi.nlm.nih.gov/pubmed/31720047 http://dx.doi.org/10.4110/in.2019.19.e36 |
Ejemplares similares
-
Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy
por: Kim, Da Rae, et al.
Publicado: (2017) -
Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Fas(lpr) mice
por: Lee, Hong Kyung, et al.
Publicado: (2020) -
Effect of Human Mesenchymal Stem Cells on Xenogeneic T and B Cells Isolated from Lupus-Prone MRL.Fas(lpr) Mice
por: Lee, Hong Kyung, et al.
Publicado: (2020) -
CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms
por: Lee, Hong Kyung, et al.
Publicado: (2017) -
Effect of a Combination of Prednisone or Mycophenolate Mofetil and Mesenchymal Stem Cells on Lupus Symptoms in MRL.Fas(lpr) Mice
por: Lee, Hong Kyung, et al.
Publicado: (2018)